Zhejiang Garden Biopharmaceutical Co.,Ltd. held its 1st Extraordinary General Meeting of 2024 on 22 February 2024, during were approved Wei Zhonglan, non-independent director, Fang Fusheng, non-independent director, Yang Qiwei, independent director and Li Guowei, independent director.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.51 CNY | +5.14% |
|
-1.96% | +22.86% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+22.86% | 1.06B | |
+25.40% | 45.35B | |
+38.38% | 24.34B | |
+26.79% | 16.51B | |
+21.19% | 14.6B | |
+71.91% | 14.27B | |
-0.05% | 6.79B | |
-11.63% | 6.57B | |
+15.08% | 5.76B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- 300401 Stock
- News Zhejiang Garden Biopharmaceutical Co.,Ltd.
- Zhejiang Garden Biopharmaceutical Co.,Ltd. Announces Board Appointments